Table 4. Anthropometric measurements, blood pressure, plasma glucose and serum lipids according to dietary oil category.

Variable	Category of dietary oil			Ptrend- value
	Polyunsaturated fatty acids (n = 450)	Mixed polyunsaturated and monounsaturated fatty acids (n = 407)	Monounsaturated fatty acids (n = 323)
Data are presented as means ± SD or n (%).
Dietary oil intake, g/d	36.9 ± 25.5	35.4 ± 25.3	31.6 ± 27.0	0.01
Body mass index, kg/m2	24.3 ± 3.2	24.8 ± 3.3	24.1 ± 3.2	0.56
General obesity	61 (13.6%)	59 (14.5%)	35 (10.8%)	0.33
Waist circumference, cm	83.8 ± 15.7	85.1 ± 14.8	85.2 ± 14.5	0.18
Waist-to-hip ratio	0.89 ± 0.06	0.89 ± 0.08	0.89 ± 0.07	0.71
Central obesity	77 (17.1%)	61 (15.0%)	57 (17.7%)	0.92
Systolic blood pressure, mmHg	136.5 ± 18.0	137.4 ± 17.4	136.9 ± 18.1	0.73
Diastolic blood pressure, mmHg	75.9 ± 10.2	79.2 ± 10.8	78.6 ± 11.0	0.0002
Use of antihypertensive drugs	216 (48.0%)	194 (47.7%)	144 (44.6%)	0.37
Fasting plasma glucose, mmol/L	6.08 ± 1.61	6.16 ± 1.72	6.16 ± 1.76	0.57
Use of antidiabetic drugs	54 (12.0%)	43 (10.6%)	32 (9.9%)	0.35
Serum triglycerides, mmol/L	1.54 ± 0.79	1.66 ± 1.07	1.74 ± 1.20	0.02
Serum total cholesterol, mmol/L	4.92 ± 1.07	5.08 ± 1.13	5.16 ± 1.16	0.008
Serum high-density lipoprotein cholesterol, mmol/L	1.47 ± 0.38	1.50 ± 0.51	1.49 ± 0.42	0.51
Serum low-density lipoprotein cholesterol, mmol/L	2.85 ± 0.88	3.00 ± 0.88	3.00 ± 0.94	0.03
Use of fibrates	0	1 (0.3%)	0	0.89
Use of statins	18 (4.0%)	18 (4.4%)	15 (4.6%)	0.66